- 1. fowl adenovirus 1
- [A serotype of the species Fowl adenovirus A. ( MSH )] (UMLS (CSP) C0242169) =Virus
| - 12. Fowlpox-CEA-TRICOM Vaccine/Vaccinia-CEA-TRICOM Vaccine
- (UMLS (NCI) C1134692) =Therapeutic or Preventive Procedure ;
|
- 2. fowl paralysis
- [highly contagious virus disease of poultry that is characterized especially by proliferation of lymphoid cells and is caused by a herpesvirus having several serotypes. ( CSP )] (UMLS (CSP) C0024793) =Neoplastic Process ;
=Herpesviridae disease;
lymphoma;
Lymphoproliferative Disorder;
Tumor Virus Infections | - 13. Fowlpox-PSA Vaccine
- [A cancer vaccine consisting of a recombinant fowlpox virus encoding human prostate-specific antigen (PSA). Administration of this agent may stimulate a cytotoxic T cell response against PSA-expressing tumor cells. Fowlpox virus is an attractive vector because its genome is easy to manipulate and it is replication incompetent in mammalian cells. (NCI04) ( NCI )] (UMLS (NCI) C1134640) Recombinant Fowlpox-Prostate Specific Antigen;
Recombinant Fowlpox-Prostate Specific Antigen Vaccine;
Recombinant Fowlpox-PSA;
Recombinant Fowlpox-PSA Vaccine;
rF-PSA =Pharmacologic Substance; Immunologic Factor ;
|
- 3. Fowler's Position
- [A semi-sitting position whereby the head of an adjustable bed is elevated to the desired height, about 60-90 cm, to produce angulation of the body, usually 45 to 60 degrees. Knees may or may not be bent. ( NCI )] (UMLS (NCI) C0277811) =Spatial Concept
| - 14. Fowlpox-PSA Vaccine/Sargramostim
- (UMLS (NCI) C1327775) =Therapeutic or Preventive Procedure ;
|
- 4. Fowlpox Vaccine
- [A recombinant virus-based vaccine that contains various peptide antigens. Fowlpox virus is an attractive vector because its genome is easy to manipulate and it does not multiply in human tissues. Strong CD8 T cell responses may be induced after prolonged immunization and have been associated with tumor regression. ( NCI )] (UMLS (NCI) C0796601) Fowlpox Virus Vaccine =Pharmacologic Substance; Immunologic Factor ;
| - 15. Fowlpox-PSA-TRICOM Vaccine
- [Synthetic fowlpox viral vaccines containing a tumor-associated antigen derived from prostate specific antigen (PSA), and a TRIad of COstimulatory Molecules (B7-1, ICAM-1 and LFA-3). Vaccination with this viral vaccine may enhance antigen presentation and activate cytotoxic T-cells against PSA-expressing tumor cells. ( NCI )] (UMLS (NCI) C1327972) fPSA-TRI =Pharmacologic Substance; Immunologic Factor
|
- 5. fowlpox virus
- [The type species of the genus AVIPOXVIRUS. It is the etiologic agent of FOWLPOX. ( MSH )] (UMLS (CSP) C0016630) =Virus
| - 16. Fowlpox-PSA-TRICOM Vaccine/Fowlpox-Sargramostim Vaccine/Vaccinia-Prostate-Specific Antigen-TRICOM Vaccine
- (UMLS (NCI) C1327976) =Therapeutic or Preventive Procedure ;
|
- 6. fowlpox virus vaccine vector/gp100 antigen/interleukin-2
- (UMLS (NCI) C1134602) Fowlpox Virus Vaccine/gp100 Antigen/Interleukin-2 =Therapeutic or Preventive Procedure
| - 17. Fowlpox-PSA-TRICOM Vaccine/Sargramostim/Vaccinia-Prostate-Specific Antigen-TRICOM Vaccine
- (UMLS (NCI) C1327975) =Therapeutic or Preventive Procedure ;
|
- 7. Fowlpox Virus Vaccine/Interleukin-2
- (UMLS (NCI) C0796602) FOWLVAC/IL-2 =Therapeutic or Preventive Procedure
| - 18. Fowlpox-PSA-TRICOM Vaccine/Vaccinia-Prostate-Specific Antigen-TRICOM Vaccine
- (UMLS (NCI) C1327974) =Therapeutic or Preventive Procedure ;
|
- 8. Fowlpox Virus Vaccine/Interleukin-2/Vaccinia-Tyrosinase Vaccine
- (UMLS (NCI) C0796658) =Therapeutic or Preventive Procedure
| - 19. Fowlpox-Sargramostim
- [A cancer vaccine adjuvant consisting of a recombinant fowlpox virus encoding human granulocyte-macrophage colony-stimulating factor (GM-CSF). GM-CSF binds to specific cell surface receptors on various immuno-hematopoietic cell types, enhancing their proliferation and differentiation and stimulating macrophage and dendritic cell functions in antigen presentation and antitumor cell-mediated immunity. Administration of recombinant fowlpox GM-CSF vaccine adjuvant may induce an immune response against tumor cells. Fowlpox virus is an attractive vector because its genome is easy to manipulate and it is replication incompetent in mammalian cells. ( NCI )] (UMLS (NCI) C1134686) Recombinant Fowlpox GM-CSF Vaccine Adjuvant;
rF-GM-CSF;
rF-Sargramostim =Pharmacologic Substance; Immunologic Factor ;
|
- 9. fowlpox-CEA-B7.1/ICAM-1/LFA-3
- [A cancer vaccine comprised of a recombinant fowlpox virus vector encoding the carcinoembryonic antigen (CEA) and a TRIad of COstimulatory Molecules (B7-1, ICAM-1 and LFA-3) (TRICOM). This agent may enhance CEA presentation to antigen presenting cells (APC) and activate cytotoxic T-cells against CEA-expressing tumors. (NCI04) ( NCI )] (UMLS (NCI) C0935790) Recombinant Fowlpox-CEA(6D)/TRICOM Vaccine;
Recombinant Fowlpox-CEA-TRICOM Vaccine;
rF-CEA(6D)TRICOM;
=Pharmacologic Substance; Immunologic Factor ;
| - 20. Fowlpox-Sargramostim Vaccine/Fowlpox-TRICOM Vaccine
- (UMLS (NCI) C1328078) =Therapeutic or Preventive Procedure ;
|
- 10. Fowlpox-CEA-TRICOM Vaccine/Sargramostim
- (UMLS (NCI) C1134687) =Therapeutic or Preventive Procedure
| - 21. Fowlpox-Tyrosinase Vaccine/Interleukin-2/Vaccinia-Tyrosinase Vaccine
- (UMLS (NCI) C1327885) =Therapeutic or Preventive Procedure ;
|
- 11. Fowlpox-CEA-TRICOM Vaccine/Sargramostim/Vaccinia-CEA-TRICOM Vaccine
- (UMLS (NCI) C1134693) =Therapeutic or Preventive Procedure ;
| |
home
